The Journal of Thoracic and Cardiovascular Surgery
Volume 138, Issue 3 , Pages 760-767 , September 2009

In vitro modeling of nonhypoxic cold ischemia–reperfusion simulating lung transplantation

  • Monica Casiraghi, MD

      Affiliations

    • Division of Cardiothoracic Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC
    • Department of Thoracic Surgery, Division of Thoracic Surgery, European Institute of Oncology, Milan, Italy
    • ,
  • Jason R. Tatreau, BS

      Affiliations

    • Cystic Fibrosis/Pulmonary Research and Treatment Center and the Division of Pulmonary and Critical Care Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC
    • ,
  • John B. Abano, MD

      Affiliations

    • Division of Cardiothoracic Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC
    • ,
  • John W. Blackwell, BS

      Affiliations

    • Division of Cardiothoracic Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC
    • ,
  • Larry Watson, MD

      Affiliations

    • Division of Cardiothoracic Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC
    • ,
  • Keith Burridge, PhD

      Affiliations

    • Department of Cell and Developmental Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC
    • ,
  • Scott H. Randell, PhD

      Affiliations

    • Cystic Fibrosis/Pulmonary Research and Treatment Center and the Division of Pulmonary and Critical Care Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC
    • ,
  • Thomas M. Egan, MD, MSc

      Affiliations

    • Division of Cardiothoracic Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC
    • Corresponding Author InformationAddress for reprints: Thomas M. Egan, MD, MSc, Division of Cardiothoracic Surgery, Department of Surgery, University of North Carolina at Chapel Hill, 3040 Burnett-Womack Bldg, CB #7065, Chapel Hill, NC 27599-7065.

Received 1 December 2008 ,Revised 2 April 2009 ,Accepted 26 May 2009.

References 

  1. Egan TM, Lambert CJ, Reddick RL, Ulicny KS, Keagy BA, Wilcox BR. A strategy to increase the donor pool: the use of cadaver lungs for transplantation. Ann Thorac Surg. 1991;52:1113–1121
  2. Steen S, Sjoberg T, Pierre L, Liao Q, Eriksson L, Algotsson L. Transplantation of lungs from a non-heart beating donor. Lancet. 2001;357:825–829
  3. Van Raemdonck DE, Rega FR, Neyrinck AP, Jannis N, Verleden GM, Lerut TE. Non-heart-beating donors. Semin Thorac Cardiovasc Surg. 2004;16:309–321
  4. Roberts CS, D'Armini AM, Egan TM. Canine double-lung transplantation with cadaver donors. J Thorac Cardiovasc Surg. 1996;112:577–583
  5. King RC, Binns OAR, Rodriguez F, Kanithanon RC, Daniel TM, Spotnitz WD, et al. Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation. Ann Thorac Surg. 2000;69:1681–1685
  6. Daud SA, Yusen RD, Meyers BF, Chakinala MM, Walter MJ, Aloush AA, et al. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med. 2007;175:507–513
  7. de Perrot M, Liu M, Waddell TK, Keshavjee S. Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med. 2003;167:490–511
  8. Pinsky DJ. The vascular biology of heart and lung preservation for transplantation. Thromb Haemost. 1995;74:58–65
  9. Wu Q, Lu Z, Verghese MW, Randell SH. Airway epithelial cell tolerance to. Pseudomonas aeruginosa. Respir Res. 2005;6:26
  10. van Belle G, Fisher L, Heagerty P, Lumley T. Biostatistics: a methodology for the health sciences. Hoboken, NJ: John Wiley and Sons; 2004;
  11. Powell CS, Jackson RM. Mitochondrial complex I, aconitase, and succinate dehydrogenase during hypoxia-reoxygenation: modulation of enzyme activities by MnSOD. Am J Physiol Lung Cell Mol Physiol. 2003;285:L189–L198
  12. Zhang X, Bedard EL, Potter R, Zhong R, Alam J, Choi AM, et al. Mitogen-activated protein kinases regulate HO-1 gene transcription after ischemia-reperfusion lung injury. Am J Physiol Lung Cell Mol Physiol. 2002;283:L815–L829
  13. Koukoulis G, Caldwell R, Inokawa H, Button B, Sevala M, Lyles JD, et al. Trends in lung pH and PO2 after circulatory arrest: implications for non-heart-beating donors and cell culture models of lung ischemia-reperfusion injury. J Heart Lung Transplant. 2005;24:2218–2225
  14. Date H, Matsumura A, Manchester JK, Cooper JM, Lowry OH, Cooper JD. Changes in alveolar oxygen and carbon dioxide concentration and oxygen consumption during lung preservation: the maintenance of aerobic metabolism during lung preservation. J Thorac Cardiovasc Surg. 1993;105:492–501
  15. Dudek SM, Garcia JG. Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol. 2001;91:1487–1500
  16. Bhabra MS, Hopkinson DN, Shaw TE, Onwu N, Hooper TL. Controlled reperfusion protects lung grafts during a transient early increase in permeability. Ann Thorac Surg. 1998;65:187–192
  17. Fischer S, Cassivi SD, Xavier AM, Cardella JA, Cutz E, Edwards V, et al. Cell death in human lung transplantation: apoptosis induction in human lungs during ischemia and after transplantation. Ann Surg. 2000;231:424–431
  18. Bogatcheva NV, Dudek SM, Garcia JG, Verin AD. Mitogen-activated protein kinases in endothelial pathophysiology. J Investig Med. 2003;51:341–352
  19. Hall SM, Evans J, Haworth SG. Influence of cold preservation on the cytoskeleton of cultured pulmonary arterial endothelial cells. Am J Respir Cell Mol Biol. 1993;9:106–114
  20. Hall SM, Komai H, Reader J, Haworth SG. Donor lung preservation: effect of cold preservation fluids on cultured pulmonary endothelial cells. Am J Physiol Lung Cell Mol Physiol. 1994;267:L508–L517
  21. Cardella JA, Keshavjee S, Mourgeon E, Cassivi SD, Fischer S, Isowa N, et al. A novel cell culture model for studying ischemia-reperfusion injury in lung transplantation. J Appl Physiol. 2000;89:1553–1560
  22. Inoue K, Suzuki S, Kubo H, Ishida I, Ueda S, Kondo T. Effects of rewarming on nuclear factor-kappaB and interleukin 8 expression in cold-preserved alveolar epithelial cells. Transplantation. 2003;76:409–415
  23. O'Neill LA. Targeting signal transduction as a strategy to treat inflammatory diseases. Nat Rev Drug Discov. 2006;5:549–563
  24. Zanotti G, Casiraghi M, Abano JB, Tatreau JR, Sevala M, Berlin H, et al. Novel critical role of toll-like receptor 4 in lung ischemia-reperfusion injury and edema. Am J Physiol Lung Cell Mol Physiol. 2009;297:L52–L63Epub ahead of print 14 April 2009
  25. Naidu BV, Krishnadasan B, Farivar AS, Woolley SM, Thomas R, Van Rooijen N, et al. Early activation of the alveolar macrophage is critical to the development of lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg. 2003;126:200–207
  26. Wolf PS, Merry HE, Farivar AS, McCourtie AS, Mulligan MS. Stress-activated protein kinase inhibition to ameliorate lung ischemia reperfusion injury. J Thorac Cardiovasc Surg. 2008;135:656–665
  27. Matthay MA, Robriquet L, Fang X. Alveolar epithelium: role in lung fluid balance and acute lung injury. Proc Am Thorac Soc. 2005;2:206–213
  28. Killinger WAJ, Dorofi DB, Keagy BA, Johnson GJ. Endothelial cell preservation using organ storage solutions. Transplantation. 1992;53:979–982

 Dr Casiraghi was a visiting research scholar at the UNC–Chapel Hill Division of Cardiothoracic Surgery from San Raffaele Hospital, Milan, Italy.

 Supported by a Cystic Fibrosis Foundation grant EGAN02P0 (TME) and National Institute of Health grants R01 HL63159 (TME), RO1 HL080322 (SHR), and PO1 HL45100 (KB).

PII: S0022-5223(09)00815-0

doi: 10.1016/j.jtcvs.2009.05.037

The Journal of Thoracic and Cardiovascular Surgery
Volume 138, Issue 3 , Pages 760-767 , September 2009

Article Tools

* Image Usage & Resolution